Theravance Biopharma annual gross profit
2012
2013
2014
2015
2016
2017
Theravance Biopharma Gross Profit Growth & History (TBPH)
Theravance Biopharma's gross profit was $9.4M for fiscal 2017.
View full Theravance Biopharma company overviewTheravance Biopharma annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2017 | 2017-12-31 | $9.4M | −$36.4M | −79.55% |
| 2016 | 2016-12-31 | $45.8M | $8.3M | +22.11% |
| 2015 | 2015-12-31 | $37.5M | $29.8M | +391.07% |
| 2014 | 2014-12-31 | $7.6M | $7.4M | +3276.11% |
| 2013 | 2013-12-31 | $226,000 | −$129.9M | −99.83% |
| 2012 | 2012-12-31 | $130.1M | — | — |
Theravance Biopharma quarterly gross profit
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2017 | 2017-12-31 | $1.4M | −$3.1M | −69.23% |
| Q3 2017 | 2017-09-30 | $3.3M | −$15.5M | −82.45% |
| Q2 2017 | 2017-06-30 | $2.1M | −$2.7M | −55.62% |
| Q1 2017 | 2017-03-31 | $2.5M | −$15.1M | −85.70% |
| Q4 2016 | 2016-12-31 | $4.5M | $3.9M | +555.99% |
| Q3 2016 | 2016-09-30 | $18.7M | $8.6M | +85.26% |
| Q2 2016 | 2016-06-30 | $4.8M | −$1.8M | −27.09% |
| Q1 2016 | 2016-03-31 | $17.6M | −$2.4M | −11.97% |
| Q4 2015 | 2015-12-31 | $693,000 | $2.5M | — |
| Q3 2015 | 2015-09-30 | $10.1M | $4.2M | +69.55% |
| Q2 2015 | 2015-06-30 | $6.6M | $3.9M | +145.97% |
| Q1 2015 | 2015-03-31 | $20.0M | $19.3M | +2545.97% |
| Q4 2014 | 2014-12-31 | −$1.8M | −$2.0M | — |
| Q3 2014 | 2014-09-30 | $6.0M | $5.9M | +24762.50% |
| Q2 2014 | 2014-06-30 | $2.7M | $2.7M | +53800.00% |
| Q1 2014 | 2014-03-31 | $757,000 | $735,000 | +3340.91% |
| Q4 2013 | 2013-12-31 | $175,000 | — | — |
| Q3 2013 | 2013-09-30 | $24,000 | — | — |
| Q2 2013 | 2013-06-30 | $5,000 | — | — |
| Q1 2013 | 2013-03-31 | $22,000 | — | — |
Theravance Biopharma gross profit trends
Over the last five fiscal years, Theravance Biopharma's gross profit decreased from $130.1M to $9.4M, a change of −$120.8M. The latest reported quarter, Q4 2017, shows $1.4M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Theravance Biopharma source filings ↗